# K021878: Eska Modular Hip System Acetabular Components

- Pathway: 510(k) (Traditional)
- Applicant: Eska America Corp.
- Decided: Mar 4, 2003 after 270 days
- Product code: LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3358
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) PFC Total Hip System: named in the summary without a submission number
- (no number) ESKA Modular Hip System: named in the summary without a submission number
- (no number) Vitalock Acetabular System: named in the summary without a submission number
- (no number) PCA Cluster Acetabular System: named in the summary without a submission number

## Indications for use
The ESKA Modular Total Hip System Acetabular Components are indicated fix uncemented use in the treatment of severely disabled hip joints resulting from painhl osteu, rheumatoid, and post-traumatic arthritis, and the late stages of avascular necrosis, and for revision of previous hip surgeries.

Source page: https://510kreport.com/device/K021878
Methodology: https://510kreport.com/methodology